Figure 2
Kaplan-Meier estimates for (a) overall survival and (b) disease-free survival according to LAPTM4B-35 expression for all head and neck carcinomas. Patients with high LAPTM4B-35 expression had a significantly worse DFS.
Figure 2 | Scientific Reports
